Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENTA Enanta Pharmaceuticals Inc.

已收盘 11-21 16:00:00 EST

9.31

+0.23

+2.53%

盘后9.10

-0.21-2.26%

17:49 EST

最高9.42	最低8.72	成交量26.44万
今开9.02	昨收9.08	日振幅7.71%
总市值1.97亿	流通市值1.52亿	总股本2,119万
成交额239.46万	换手率1.62%	流通股本1,627万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENTA","market":"US","secType":"STK","nameCN":"Enanta Pharmaceuticals Inc.","latestPrice":9.31,"timestamp":1732222800000,"preClose":9.08,"halted":0,"volume":264381,"hourTrading":{"tag":"盘后","latestPrice":9.1,"preClose":9.31,"latestTime":"17:49 EST","volume":27108,"amount":252323.38,"timestamp":1732229350846},"delay":0,"floatShares":16274487,"shares":21188571,"eps":-5.459748,"marketStatus":"已收盘","marketStatusCode":5,"change":0.23,"latestTime":"11-21 16:00:00 EST","open":9.02,"high":9.42,"low":8.72,"amount":2394610.8145439997,"amplitude":0.077093,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.459748,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732266000000},"adr":0,"listingDate":1363838400000,"adjPreClose":9.08,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":9.1,"preClose":9.31,"latestTime":"17:49 EST","volume":27108,"amount":252323.38,"timestamp":1732229350846},"volumeRatio":1.88961,"impliedVol":2.2201,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/ENTA","defaultTab":"news","newsList":[{"id":"2483584815","title":"Enanta Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.23%报9.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483584815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483584815?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:34","pubTimestamp":1731699260,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时34分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.23%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.85%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir，其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116033421abc5733b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116033421abc5733b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2479080261","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080261?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:30","pubTimestamp":1730381453,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时30分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速跳水6.79%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Aerovate Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Evogene Ltd.涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为188.62%、184.32%、144.61%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Equillium, Inc.、Enanta Pharmaceuticals, Inc.，振幅分别为21.98%、12.32%、6.96%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213053971a3843&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213053971a3843&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2478766702","title":"Enanta Pharmaceuticals, Inc.盘中异动 快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478766702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478766702?lang=zh_cn&edition=full","pubTime":"2024-10-25 03:56","pubTimestamp":1729799793,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日03时56分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.02%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Monopar Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Quince Therapeutics, Inc.涨幅较大，Monopar Therapeutics Inc.、Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为517.64%、303.11%、214.20%，振幅较大的相关个股有Monopar Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.，振幅分别为726.35%、78.77%、71.78%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025035634a1e7d864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025035634a1e7d864&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2477953620","title":"Enanta Pharmaceuticals, Inc.盘中异动 大幅跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477953620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477953620?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:07","pubTimestamp":1729692430,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时07分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.08%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.29%。其相关个股中，Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1497.14%、762.48%、330.05%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为71.86%、68.32%、64.38%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322071198e3e027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102322071198e3e027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2473472469","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.02%报10.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473472469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473472469?lang=zh_cn&edition=full","pubTime":"2024-10-08 23:17","pubTimestamp":1728400674,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日23时17分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.02%。截至发稿，该股报10.97美元/股，成交量7.8045万股，换手率0.37%，振幅4.87%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir，其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082317549719f014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082317549719f014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2472305006","title":"Enanta Pharmaceuticals, Inc.盘中异动 临近午盘大幅拉升5.12%报10.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472305006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472305006?lang=zh_cn&edition=full","pubTime":"2024-10-02 00:00","pubTimestamp":1727798419,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日00时00分，Enanta Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.12%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir，其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020000199719dbdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410020000199719dbdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2460056828","title":"Enanta Pharmaceuticals, Inc.盘中异动 快速上涨5.16%报12.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460056828","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460056828?lang=zh_cn&edition=full","pubTime":"2024-08-19 23:39","pubTimestamp":1724081974,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日23时39分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.16%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为6588.48%、3189.65%、985.02%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为405.90%、220.18%、100.99%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819233934ab5e6ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819233934ab5e6ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALZN","ENTA","BK4539"],"gpt_icon":0},{"id":"2459760084","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.36%报12.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459760084","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459760084?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:37","pubTimestamp":1723732647,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时37分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.36%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir，其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815223728ab5ddb19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815223728ab5ddb19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2459065106","title":"Enanta Pharmaceuticals, Inc.盘中异动 快速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459065106","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459065106?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:16","pubTimestamp":1723648572,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时16分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.08%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为86.50%、73.74%、65.90%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814231613ab5db0f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814231613ab5db0f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2458855697","title":"Enanta Pharmaceuticals, Inc.2024财年第二财季实现净利润-22.66百万美元，同比增加42.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458855697","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458855697?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:09","pubTimestamp":1723392591,"startTime":"0","endTime":"0","summary":"8月12日，Enanta Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-22.66百万美元，同比增加42.00%；其中营业收入为17.97百万美元，同比减少4.87%，每股基本收益为-1.07美元。机构评级：截至2024年8月12日，当前有8家机构对Enanta Pharmaceuticals, Inc.目标价做出预测，其中目标均价为19.62美元，其中最低目标价为10.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009599f2225aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009599f2225aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA"],"gpt_icon":0},{"id":"2458516951","title":"Enanta Pharmaceuticals, Inc.盘中异动 快速跳水5.00%报12.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458516951","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458516951?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:16","pubTimestamp":1723220184,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时16分，Enanta Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.00%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.02%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Azitra Inc、Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为413.33%、87.48%、65.27%，振幅较大的相关个股有Azitra Inc、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为90.93%、51.14%、37.04%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810001624af96d6bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810001624af96d6bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2458419833","title":"Enanta Pharmaceuticals, Inc.盘中异动 急速拉升5.17%报13.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458419833","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458419833?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:12","pubTimestamp":1723133524,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时12分，Enanta Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.17%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.63%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为391.74%、290.65%、184.92%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为117.21%、54.41%、45.58%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809001204af96a253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809001204af96a253&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2457841714","title":"Enanta Pharmaceuticals, Inc.盘中异动 急速跳水8.07%报11.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457841714","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457841714?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:34","pubTimestamp":1723037669,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时34分，Enanta Pharmaceuticals, Inc.股票出现异动，股价急速跳水8.07%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir，其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072134299585f274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072134299585f274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2456849592","title":"Enanta Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456849592","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456849592?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:33","pubTimestamp":1722605612,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时33分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.13%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为325.42%、88.86%、19.77%，振幅较大的相关个股有Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Dermata Therapeutics, Inc.，振幅分别为33.34%、17.87%、15.32%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213332aefcf897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213332aefcf897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2456285594","title":"Enanta Pharmaceuticals Inc    预计每股亏损 1.45 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456285594","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456285594?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:01","pubTimestamp":1722603688,"startTime":"0","endTime":"0","summary":"   * Enanta Pharmaceuticals Inc    预计在8月5日公布截至2024年6月30日的业绩报告时，季度收入将出现下降(预计)。* LSEG 分析师对 Enanta Pharmaceuticals Inc 的平均预期是每股亏损 1.45 美元。* 华尔街对 Enanta Pharmaceuticals Inc 的 12 个月目标价中位数为 22.00 美元，高于其最新收盘价 14.81 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Enanta Pharmaceuticals Inc    预计每股亏损 1.45 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTA"],"gpt_icon":0},{"id":"2452699432","title":"Enanta Pharmaceuticals, Inc.盘中异动 快速跳水5.03%报15.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452699432","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452699432?lang=zh_cn&edition=full","pubTime":"2024-07-19 00:55","pubTimestamp":1721321725,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日00时55分，Enanta Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.03%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。其相关个股中，Onconetix, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silo Pharma, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为2478.94%、2417.80%、1241.51%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719005526941f862a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719005526941f862a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2451523679","title":"Enanta Pharmaceuticals, Inc.盘中异动 快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451523679","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451523679?lang=zh_cn&edition=full","pubTime":"2024-07-16 01:56","pubTimestamp":1721066217,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日01时56分，Enanta Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.06%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scinai Immunotherapeutics Ltd涨幅较大，Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为3345.51%、162.30%、135.84%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scinai Immunotherapeutics Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为150.36%、91.37%、74.53%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716015657af926a88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716015657af926a88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2450539172","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450539172","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450539172?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:12","pubTimestamp":1720793537,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时12分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.27%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为1667.02%、88.93%、41.22%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为80.37%、48.15%、32.83%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221217af921e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221217af921e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTA","BK4139"],"gpt_icon":0},{"id":"2450407278","title":"Enanta Pharmaceuticals, Inc.盘中异动 临近收盘急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450407278","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450407278?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:48","pubTimestamp":1720554529,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时48分，Enanta Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.19%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。AbbVie销售蛋白酶抑制剂paritaprevir，其他抑制剂正在研发中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710034850af9161a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710034850af9161a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTA"],"gpt_icon":0},{"id":"2449704325","title":"Enanta Pharmaceuticals, Inc.盘中异动 股价大涨5.15%报14.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449704325","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449704325?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:55","pubTimestamp":1720450552,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时55分，Enanta Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.15%。Enanta Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Enanta Pharmaceuticals, Inc.公司简介：Enanta Pharmaceuticals Inc是一家美国生物科技公司，致力于研究和开发用于治疗病毒感染和肝脏疾病的分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082255539681aae0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082255539681aae0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRPX","BK4139","ENTA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enanta.com","stockEarnings":[{"period":"1week","weight":-0.1294},{"period":"1month","weight":-0.2816},{"period":"3month","weight":-0.2753},{"period":"6month","weight":-0.2452},{"period":"1year","weight":-0.0893},{"period":"ytd","weight":-0.0351}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0118},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1153},{"period":"1year","weight":0.3028},{"period":"ytd","weight":0.2423}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Enanta Pharmaceuticals, Inc.于1995年根据特拉华州法律注册成立。该公司是一家生物技术公司，利用稳健、化学驱动的方法和药物发现能力，成为小分子药物发现和开发的领导者，重点是病毒感染的治疗。该公司发现了gleCAPrevir，这是通过与艾伯维合作发现和开发的两种蛋白酶抑制剂中的第二种，用于治疗丙型肝炎病毒（HCV）的慢性感染。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.067315},{"month":2,"riseRate":0.545455,"avgChangeRate":0.028424},{"month":3,"riseRate":0.636364,"avgChangeRate":0.006788},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.022127},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.054534},{"month":6,"riseRate":0.5,"avgChangeRate":0.028981},{"month":7,"riseRate":0.5,"avgChangeRate":-0.007618},{"month":8,"riseRate":0.5,"avgChangeRate":0.01052},{"month":9,"riseRate":0.25,"avgChangeRate":-0.043774},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.014748},{"month":11,"riseRate":0.666667,"avgChangeRate":0.063449},{"month":12,"riseRate":0.727273,"avgChangeRate":0.017471}],"exchange":"NASDAQ","name":"Enanta Pharmaceuticals Inc.","nameEN":"Enanta Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Enanta Pharmaceuticals Inc.,ENTA,Enanta Pharmaceuticals Inc.股票,Enanta Pharmaceuticals Inc.股票老虎,Enanta Pharmaceuticals Inc.股票老虎国际,Enanta Pharmaceuticals Inc.行情,Enanta Pharmaceuticals Inc.股票行情,Enanta Pharmaceuticals Inc.股价,Enanta Pharmaceuticals Inc.股市,Enanta Pharmaceuticals Inc.股票价格,Enanta Pharmaceuticals Inc.股票交易,Enanta Pharmaceuticals Inc.股票购买,Enanta Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Enanta Pharmaceuticals Inc.(ENTA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Enanta Pharmaceuticals Inc.(ENTA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}